These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29182762)

  • 1. Cognitive Function Among Antiretroviral Treatment-Naive Individuals Infected With Human Immunodeficiency Virus Type 1 Subtype G Versus CRF02_AG in Nigeria.
    Jumare J; Ndembi N; El-Kamary SS; Magder L; Hungerford L; Burdo T; Eyzaguirre LM; Dakum P; Umlauf A; Cherner M; Abimiku A; Charurat M; Blattner WA; Royal W
    Clin Infect Dis; 2018 Apr; 66(9):1448-1453. PubMed ID: 29182762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High resistance to reverse transcriptase inhibitors among persons infected with human immunodeficiency virus type 1 subtype circulating recombinant form 02_AG in Ghana and on antiretroviral therapy.
    Deletsu SD; Maina EK; Quaye O; Ampofo WK; Awandare GA; Bonney EY
    Medicine (Baltimore); 2020 Feb; 99(7):e18777. PubMed ID: 32049783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma HIV RNA level is associated with neurocognitive function among HIV-1-infected patients in Nigeria.
    Jumare J; El-Kamary SS; Magder L; Hungerford L; Ndembi N; Aliyu A; Dakum P; Umlauf A; Cherner M; Abimiku A; Charurat M; Blattner WA; Royal W
    J Neurovirol; 2018 Dec; 24(6):712-719. PubMed ID: 30168015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of drug resistance among B and the most prevalent non-B HIV type 1 subtypes (C, F, and CRF02_AG) in Italy.
    Santoro MM; Alteri C; Ronga L; Flandre P; Fabeni L; Mercurio F; D'Arrigo R; Gori C; Palamara G; Bertoli A; Forbici F; Salpini R; Boumis E; Tozzi V; Visco-Comandini U; Zaccarelli M; Van Houtte M; Pattery T; Narciso P; Antinori A; Ceccherini-Silberstein F; Perno CF
    AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1285-93. PubMed ID: 22417570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B.
    Scherrer AU; Ledergerber B; von Wyl V; Böni J; Yerly S; Klimkait T; Bürgisser P; Rauch A; Hirschel B; Cavassini M; Elzi L; Vernazza PL; Bernasconi E; Held L; Günthard HF;
    Clin Infect Dis; 2011 Dec; 53(11):1143-52. PubMed ID: 21998284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gag P2/NC and pol genetic diversity, polymorphism, and drug resistance mutations in HIV-1 CRF02_AG- and non-CRF02_AG-infected patients in Yaoundé, Cameroon.
    Teto G; Tagny CT; Mbanya D; Fonsah JY; Fokam J; Nchindap E; Kenmogne L; Njamnshi AK; Kanmogne GD
    Sci Rep; 2017 Oct; 7(1):14136. PubMed ID: 29074854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of new, emerging HIV-1 unique recombinant forms and drug resistant viruses circulating in Cameroon.
    Ragupathy V; Zhao J; Wood O; Tang S; Lee S; Nyambi P; Hewlett I
    Virol J; 2011 Apr; 8():185. PubMed ID: 21513545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of HIV type 1 subtype on drug resistance mutations in Nigerian patients failing first-line therapy.
    Chaplin B; Eisen G; Idoko J; Onwujekwe D; Idigbe E; Adewole I; Gashau W; Meloni S; Sarr AD; Sankalé JL; Ekong E; Murphy RL; Kanki P
    AIDS Res Hum Retroviruses; 2011 Jan; 27(1):71-80. PubMed ID: 20964479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay of reverse transcriptase inhibitor therapy and gag p6 diversity in HIV type 1 subtype G and CRF02_AG.
    Ojesina AI; Chaplin B; Sankalé JL; Murphy R; Idigbe E; Adewole I; Ekong E; Idoko J; Kanki PJ
    AIDS Res Hum Retroviruses; 2008 Sep; 24(9):1167-74. PubMed ID: 18729771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG.
    Heipertz RA; Ayemoba O; Sanders-Buell E; Poltavee K; Pham P; Kijak GH; Lei E; Bose M; Howell S; O'Sullivan AM; Bates A; Cervenka T; Kuroiwa J; Akintunde A; Ibezim O; Alabi A; Okoye O; Manak M; Malia J; Peel S; Maisaka M; Singer D; O'Connell RJ; Robb ML; Kim JH; Michael NL; Njoku O; Tovanabutra S
    Medicine (Baltimore); 2016 Aug; 95(32):e4346. PubMed ID: 27512845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France.
    Assoumou L; Bocket L; Pallier C; Grude M; Ait-Namane R; Izopet J; Raymond S; Charpentier C; Visseaux B; Wirden M; Trabaud MA; Le Guillou-Guillemette H; Allaoui C; Henquell C; Krivine A; Dos Santos G; Delamare C; Bouvier-Alias M; Montes B; Ferre V; De Monte A; Signori-Schmuck A; Maillard A; Morand-Joubert L; Tumiotto C; Fafi-Kremer S; Amiel C; Barin F; Marque-Juillet S; Courdavault L; Vallet S; Beby-Defaux A; de Rougemont A; Fenaux H; Avettand-Fenoel V; Allardet-Servent A; Plantier JC; Peytavin G; Calvez V; Chaix ML; Descamps D;
    J Antimicrob Chemother; 2019 May; 74(5):1417-1424. PubMed ID: 30753724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of antiretroviral therapy resistance-associated primary mutations among drug-naive HIV-1-infected individuals in rural western Cameroon.
    Koizumi Y; Ndembi N; Miyashita M; Lwembe R; Kageyama S; Mbanya D; Kaptue L; Numazaki K; Fujiyama Y; Ichimura H
    J Acquir Immune Defic Syndr; 2006 Sep; 43(1):15-22. PubMed ID: 16885781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral Genetic Diversity and Polymorphisms in a Cohort of HIV-1-Infected Patients Eligible for Initiation of Antiretroviral Therapy in Abuja, Nigeria.
    Diallo K; Zheng DP; Rottinghaus EK; Bassey O; Yang C
    AIDS Res Hum Retroviruses; 2015 May; 31(5):564-75. PubMed ID: 25582324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid peroxidation and total cholesterol in HAART-naïve patients infected with circulating recombinant forms of human immunodeficiency virus type-1 in Cameroon.
    Teto G; Kanmogne GD; Torimiro JN; Alemnji G; Nguemaim FN; Takou D; Nanfack A; Tazoacha A
    PLoS One; 2013; 8(6):e65126. PubMed ID: 23762297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus type 1 ((HIV-1) subtypes in the northwest region, Cameroon.
    Abongwa LE; Nyamache AK; Torimiro JN; Okemo P; Charles F
    Virol J; 2019 Aug; 16(1):103. PubMed ID: 31416460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of protease resistance-associated mutations in HIV type 1 drug-naive patients following the increasing prevalence of the CRF02_AG strain in Morocco.
    Miri L; Ouladlahsen A; Kettani A; Bensghir R; Marhoum Elfilali K; Wakrim L
    AIDS Res Hum Retroviruses; 2012 Jun; 28(6):571-7. PubMed ID: 22145994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtype-specific patterns in HIV Type 1 reverse transcriptase and protease in Oyo State, Nigeria: implications for drug resistance and host response.
    Ojesina AI; Sankalé JL; Odaibo G; Langevin S; Meloni ST; Sarr AD; Olaleye D; Kanki PJ
    AIDS Res Hum Retroviruses; 2006 Aug; 22(8):770-9. PubMed ID: 16910833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 subtype diversity and immuno-virological outcomes among adolescents failing antiretroviral therapy in Cameroon: A cohort study.
    Togna Pabo WLR; Fokam J; Njume D; Takou D; Santoro MM; Nyasa RB; Chenwi C; Mpouel ML; Beloumou G; Jagni ESN; Nka AD; Ka'e AC; Teto G; Dambaya B; Djupsa S; Gouissi Anguechia DH; Evariste M; Kamta C; Bala L; Lambo V; Halle-Ekane EG; Colizzi V; Perno CF; Ndjolo A; Ndip Ndip R
    PLoS One; 2023; 18(10):e0293326. PubMed ID: 37878637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms and drug resistance analysis of HIV-1 isolates from patients on first line antiretroviral therapy (ART) in South-eastern Nigeria.
    Udeze AO; Olaleye DO; Odaibo GN
    PLoS One; 2020; 15(4):e0231031. PubMed ID: 32267869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. V118I substitution in the reverse transcriptase gene of HIV type 1 CRF02_AG strains infecting drug-naive individuals in Cameroon.
    Konings FA; Nyambi PN
    AIDS Res Hum Retroviruses; 2004 Jun; 20(6):673-8. PubMed ID: 15242545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.